Affiliation:
1. Universidade de Coimbra, Coimbra, Portugal
Abstract
AbstractThrombocytopenia, defined as platelet count < 150,000 mm3, is frequently diagnosed by obstetricians since this parameter is included in routine surveillance during pregnancy, with an incidence of between 7 and 12%. Therefore, decisions regarding subsequent examination and management are primordial. While most of the cases are due to physiological changes, as gestational thrombocytopenia, other causes can be related to severe conditions that can lead to fetal or maternal death. Differentiating these conditions might be challenging: they can be pregnancy-specific (pre-eclampsia/HELLP syndrome [hemolysis, elevated liver enzymes, low platelets]), or not (immune thrombocytopenia purpura, thrombotic thrombocytopenic purpura or hemolytic uremic syndrome). Understanding the mechanisms and recognition of symptoms and signs is essential to decide an adequate line of investigation. The severity of thrombocytopenia, its etiology and gestational age dictates different treatment regimens.
Subject
Obstetrics and Gynecology
Reference36 articles.
1. ACOG Practice Bulletin no. 207: thrombocytopenia in pregnancy;Committee on Practice Bulletins—Obstetrics;Obstet Gynecol,2019
2. Immune thrombocytopenic purpura in pregnancy;A M Baucom;Obstet Gynecol Surv,2019
3. Review thrombocytopenia in pregnancy;B Myers;Obstet Gynaecol,2009
4. Immune thrombocytopenic purpura;A Zainal;J Community Hosp Intern Med Perspect,2019
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献